{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:29:54Z","timestamp":1769725794177,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1053\/j.semnuclmed.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T01:03:18Z","timestamp":1587776598000},"page":"283-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Imaging and Quantification of Cardiac Sarcoidosis"],"prefix":"10.1053","volume":"50","author":[{"given":"Mohamed Y.","family":"Elwazir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar F.","family":"Abou Ezzeddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0001","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC Expert Consensus Document on the Role of (18)F-FDG PET\/CT in Cardiac Sarcoid Detection and Therapy Monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0002","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0003","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0004","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0006","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: A comprehensive review","volume":"7","author":"Sekhri","year":"2011","journal-title":"Arch Med Sci."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0007","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jchf.2014.03.015","article-title":"Electrogram-guidance: A method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis","volume":"2","author":"Liang","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0008","series-title":"New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan","author":"Terasaki","year":"2019"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0009","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart rhythm"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0011","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12471-016-0847-1","article-title":"Pulmonary hypertension complicating pulmonary sarcoidosis","volume":"24","author":"Huitema","year":"2016","journal-title":"Neth Heart J."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0012","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1378\/chest.66.4.452","article-title":"Myocardial sarcoidosis presenting as acute mitral insufficiency","volume":"66","author":"Zoneraich","year":"1974","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0013","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0014","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2016.10.073","article-title":"Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography","volume":"227","author":"Schouver","year":"2017","journal-title":"Int J Cardiol."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0016","article-title":"Response to steroid therapy in cardiac sarcoidosis: Insights from myocardial strain","volume":"13","author":"Lo","year":"2019","journal-title":"Eur J Echocardiogr"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0017","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11886-018-1065-9","article-title":"Echocardiography in sarcoidosis","volume":"20","author":"Kurmann","year":"2018","journal-title":"Curr Cardiol Rep."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0018","doi-asserted-by":"crossref","unstructured":"Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs1. http:\/\/dxdoiorg\/101148\/rg241035076. 2004.","DOI":"10.1148\/rg.241035076"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0019","doi-asserted-by":"crossref","unstructured":"Jeudy J, Burke AP, White CS, et al. Cardiac Sarcoidosis: The Challenge of Radiologic-Pathologic Correlation: From the Radiologic Pathology Archives. http:\/\/dxdoiorg\/101148\/rg2015140247. 2015.","DOI":"10.1148\/rg.2015140247"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.00088612","article-title":"Imaging the inflammatory activity of sarcoidosis","volume":"41","author":"Keijsers","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0021","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10554-005-9043-x","article-title":"Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia","volume":"22","author":"Futamatsu","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000047316","article-title":"Technetium-99m sestamibi\/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis","volume":"94","author":"Eguchi","year":"2000","journal-title":"Cardiology"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0025","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol","author":"Christopoulos","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0026","article-title":"Characterization of a highly effective preparation for suppression of myocardial glucose utilization","author":"Larson","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0027","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2967\/jnumed.107.039792","article-title":"Frequent diagnostic errors in cardiac PET\/CT due to misregistration of CT attenuation and emission PET images: A definitive analysis of causes, consequences, and corrections","volume":"48","author":"Gould","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0029","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jtcvs.2012.01.061","volume":"143","author":"Patel","year":"2012","journal-title":"J Thorac Cardiovasc Surg."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2967\/jnumed.117.201368","article-title":"Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI Cardiovascular Council and the ASNC","volume":"59","author":"Murthy","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","article-title":"Myocardial blood flow and inflammatory cardiac sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0032","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcmg.2016.10.008","article-title":"Quantitative assessment of myocardial blood flow in cardiac sarcoidosis: A potential next step in the further integration of FDG-PET in imaging management?","volume":"10","author":"Chareonthaitawee","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0033","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1440-1843.2011.01966.x","article-title":"Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis","volume":"16","author":"Umeda","year":"2011","journal-title":"Respirology"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res."},{"issue":"7 Pt 1","key":"10.1053\/j.semnuclmed.2020.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jcmg.2019.01.011","article-title":"Repeatability and optimization of FDG positron emission tomography for evaluation of cardiac sarcoidosis","volume":"12","author":"Alvi","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0036","first-page":"241","article-title":"The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience","volume":"53","author":"Youssef","year":"2012"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0037","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0038","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2 Pt 2","key":"10.1053\/j.semnuclmed.2020.03.005_bib0039","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0040","first-page":"1","article-title":"FDG-PET in possiblecardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"2","author":"Tuominen","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0041","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0042","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2967\/jnumed.110.076232","article-title":"Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques","volume":"51","author":"Gotthardt","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0043","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0044","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J Card Fail."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0045","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/RLU.0b013e31827a27df","article-title":"(18)F-FDG PET\/CT for the assessment of disease extension and activity in patients with sarcoidosis: Results of a preliminary prospective study","volume":"38","author":"Ambrosini","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0046","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of theaccuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0047","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcct.2009.07.003","article-title":"What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT?","volume":"3","author":"Lin","year":"2009","journal-title":"J Cardiovasc Comput Tomogr."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0048","first-page":"234","article-title":"Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis","volume":"22","author":"Ishimaru","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0049","first-page":"399","article-title":"Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance","author":"Schulz-Menger","year":"2006","journal-title":"Heart. 92. England"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0051","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12968-019-0520-0","article-title":"Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis","volume":"21","author":"Gr\u00e4ni","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0053","doi-asserted-by":"crossref","unstructured":"Harrigan CJ, Peters DC, Gibson CM, et al. Hypertrophic Cardiomyopathy: Quantification of Late Gadolinium Enhancement with Contrast-enhanced Cardiovascular MR Imaging1. http:\/\/dxdoiorg\/101148\/radiol10090526. 2011.","DOI":"10.1148\/radiol.10090526"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0054","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0056","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: A systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circul Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0057","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: A systematic review and meta-analysis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0058","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3348\/kjr.2017.18.1.113","article-title":"Myocardial T1 and T2 mapping: Techniques and clinical applications","volume":"18","author":"Kim","year":"2017","journal-title":"Korean J Radiol."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0059","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: A meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/157488608783333989","article-title":"Gadolinium-contrast toxicity in patients with kidney disease: Nephrotoxicity and nephrogenic systemic fibrosis","volume":"3","author":"Perazella","year":"2008","journal-title":"Curr Drug Saf."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0061","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0062","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","article-title":"Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner","volume":"52","author":"Delso","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0063","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00259-011-1842-9","article-title":"Value of a Dixon-based MR\/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions","volume":"38","author":"Eiber","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0064","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s12350-015-0197-1","article-title":"Evaluation of attenuation correction in cardiac PET using PET\/MR","volume":"24","author":"Lau","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semnuclmed.2012.08.007","article-title":"MR-based motion correction for PET imaging","volume":"43","author":"Ouyang","year":"2013","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0066","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12410-013-9213-5","article-title":"State of the art in cardiac hybrid technology: PET\/MR","volume":"6","author":"Nappi","year":"2013","journal-title":"Curr Cardiovasc Imaging Rep."},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0067","first-page":"757","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0068","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circul Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0069","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0070","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of Atherosclerotic Inflammation by (68)Ga-DOTATATE PET Compared to [(18)F]FDG PET Imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0071","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res."},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2020.03.005_bib0072","first-page":"670","article-title":"Imaging cardiac sarcoidosis with FLT-PET with comparison to FDG-PET: A prospective pilot study","volume":"60","author":"Martineau","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.03.005_bib0073","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","article-title":"Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice","volume":"127","author":"Majmudar","year":"2013","journal-title":"Circulation"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:37:08Z","timestamp":1757543828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299820300349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0001299820300349"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.03.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging and Quantification of Cardiac Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}